MedTrace Logo

Dengue Seroprevalence Study in Blood Donors in the French West Indies

NCT01104740 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 817

Last updated 2021-08-20

No results posted yet for this study

Summary

Dengue is an infectious disease most prevalent in the world. This disease is endemic in the Caribbean, with an increase in seasonal rains. Several outbreaks have been observed in recent years, in 2001, 2005 and 2007, during which further particularly virulent serotypes have emerged. The clinical expression of dengue fever is variable, ranging from no symptoms to a classical form with fever, and even of severe or lethal bleeding. With the possible existence of silent forms of the disease, there are no data identifying the current level of protection of the population in Martinique / Guadeloupe.

Conditions

  • Blood Donors
  • Dengue

Interventions

OTHER

Biological sample collection

Blood (serum) sample collection

Sponsors & Collaborators

  • Sanofi Pasteur, a Sanofi Company

    collaborator INDUSTRY

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Clinique Antilles-Guyane

    collaborator OTHER

  • Etablissement Français du Sang, Martinique

    lead OTHER

Principal Investigators

  • Pascale RICHARD, MD · French Blood Establishment of Martinique

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-05-31
Completion
2012-05-31

Countries

  • Guadeloupe
  • Martinique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01104740 on ClinicalTrials.gov